Monte Rosa Therapeutics, Inc. (GLUE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.3B |
| Enterprise Value | 1.21B |
| P/E Ratio | -10.04 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 28.31 |
| Price/Book Ratio | 2.34 |
| Enterprise/Revenue | 25.49 |
| Enterprise/EBITDA | -8.86 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -3.03 |
| Operating Margin | -3.45 |
| Return On Assets | -0.18 |
| Return On Equity | -0.41 |
| Revenue | 123.67M |
| Revenue/Share | 0.66 |
| Gross Profit | 115.32M |
| EBITDA | -31.37M |
| Net Income | -38.63M |
| Diluted EPS | -0.46 |
| Total Cash | 666.22M |
| Total Cash/Share | 10.16 |
| Total Debt | 39.06M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 9.54 |
| Book Value Per Share | 7.96 |
| 52-Week Change | 302.37 |
| 52-Week High | 25.77 |
| 52-Week Low | 4.12 |
| Moving Average 50 Days | 18.69 |
| Moving Average 200 Days | 15.91 |
| Average Volume | 980,114 |
| Shares Outstanding | 65.12M |
| % Held by Institutions | 104.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |